Yperad is a specialist medical practice in Ieper. Private Limited, started on 10 February 2025, 1 establishment.

What is the address of Yperad?

The registered office of Yperad is located at Klaverstraat 1, 8900 Ieper.

Is Yperad still active?

Yes. According to the CBE (18 September 2026) Yperad is active, legal situation “Normale toestand”, started on 10 February 2025.

Is Yperad registered on Peppol?

Yes, Yperad is registered on the Peppol network with ID 0208:1019817715.

What is the enterprise number of Yperad?

The enterprise number of Yperad is BE1019817715.

When was Yperad founded?

Yperad was founded on 10 February 2025.

Is Yperad a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 February 2025; 1 annual account filed (fiscal year 2025); 11 directors known from the annual account.

How much profit did Yperad make in 2025?

Yperad posted a profit after taxes of € 8,803 in financial year 2025.

What is the revenue of Yperad?

As a small company, Yperad is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 13,317.

How many employees does Yperad have?

According to the 2025 annual accounts, Yperad has 0 full-time equivalents (FTE).

Yperad (Private Limited) - Ieper - BE1019817715

Q: Who are the directors of Yperad?

According to the 2025 annual accounts, the directors of Yperad are: SARX, Dr. Borny Filip, DR. JULIE DESIMPEL, RADIOLOGIE, DOKTER LOUIS FLAMÉE, Dr. Capoen, Dr. Katrien Goemaere, radioloog, Dokterskabinet CVH, Dr. Johan Dehem.

Dossier Yperad, printed on 18 September 2026 from databakkes.be/en/1019817715/yperad. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Yperad from Ieper, company number BE1019817715, closed financial year 2025 with a result of € 8,803 after tax. For that financial year Yperad recorded a gross margin of € 13,317 and equity of € 19,803. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Healthy

€ 19,803

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 8,803

Profit after tax over the fiscal year.

Cash in the bank

€ 163,083

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 8,803.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1.6 million

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,077

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

What happened to Yperad?

What happened at Yperad in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 8,803. Source: NBB ↗
Feb 10, 2025 New establishment in Ieper. KBO
2025 SARX became a director. NBB
2025 Dr. Borny Filip became a director. NBB
2025 DR. JULIE DESIMPEL, RADIOLOGIE became a director. NBB
2025 DOKTER LOUIS FLAMÉE became a director. NBB
2025 Dr. Capoen became a director. NBB
2025 Dr. Katrien Goemaere, radioloog became a director. NBB

In short

Paid € 4,077 in corporate taxes since 2025.

Original PDFs at the National Bank ↗

A new publication or filing at Yperad? We notify you, reason included.

Follow Yperad

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Dr. Johan Dehem 9.1%

Dr. De Sutter Jo 9.1%

DR. JULIE DESIMPEL, RADIOLOGIE 9.1%

The stake of Dr. Johan Dehem, Dr. De Sutter Jo, DR. JULIE DESIMPEL, RADIOLOGIE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Yperad

Behind Yperad are SARX, Dr. Borny Filip, DR. JULIE DESIMPEL, RADIOLOGIE, DOKTER LOUIS FLAMÉE, Dr. Capoen and Dr. Katrien Goemaere, radioloog. The shares are held by Dr. Johan Dehem (9.1%), Dr. De Sutter Jo (9.1%) and DR. JULIE DESIMPEL, RADIOLOGIE (9.1%).

See the full network in the app